Renovo Concepts

TX - San AntonioBiotechnology1 H-1B visas (FY2023)

Focus: Renovo Concepts is a San Antonio-based biotechnology company founded in 2017 specializing in mechanical tissue resuscitation technology for neurosurgical applications. The company operates as a pre-revenue biotech with a focused pipeline addressing critical clinical needs in craniotomy and craniectomy.

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Renovo Concepts

AI assessmentNot Hiring

No open roles listed right now. Follow Renovo Concepts to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Mechanical Tissue Resuscitation

Clinical Need for Craniotomy or Craniectomy

N/A

Clinical Trials (1)

NCT06201429A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR™) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.

N/A

Help build intelligence for Renovo Concepts

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work on novel, unproven mechanical tissue technology in an underserved neurosurgical space with significant clinical need
Early-stage company founded in 2017 offers potential for substantial equity upside if mechanical tissue resuscitation approach validates
H1B sponsorship available (1 approval, 0 denials in 2023) signals openness to international talent recruitment

Watch Out For

Zero active job openings and minimal public hiring activity suggest the company is not scaling aggressively or may be in stealth/pre-commercial mode
Single trial in early pipeline with no disclosed funding, revenue, or financials creates extreme uncertainty around runway, growth trajectory, and job security
No published data, zero clinical publications, and lack of transparent milestone communication indicate limited ability to validate technology claims or attract institutional credibility

Generated by Claude from Renovo Concepts's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2017

Portfolio: 1 clinical trial

H-1B (2023): 1 approval

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub